Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
International Journal of Oncology|January 13, 2005
Selective heparanase localization in malignant melanomaBrian P Murry, Andrea Greiter-Wilke, Daniel P Paulsen, et al.Cancers|November 14, 2023
Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not MetastasisTetiana Y Bowley, Seth D Merkley, Irina V Lagutina, et al.The American Journal of Pathology|April 26, 2011
Selection of brain metastasis-initiating breast cancer cells determined by growth on hard agarLixia Guo, Dominic Fan, Fahao Zhang, et al.Nature Medicine|April 8, 2015
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytesIgnazio Caruana, Barbara Savoldo, Valentina Hoyos, et al.Neuro-Oncology|May 12, 2004
Brain metastases in melanoma: roles of neurotrophinsYvonne Denkins, Jane Reiland, Madhuchhanda Roy, et al.Science Translational Medicine|April 12, 2013
The identification and characterization of breast cancer CTCs competent for brain metastasisLixin Zhang, Lon D Ridgway, Michael D Wetzel, et al.Cancer Research Communications|January 20, 2025
A Melanoma Brain Metastasis CTC Signature and CTC:B-cell Clusters Associate with Secondary Liver Metastasis: A Melanoma Brain-Liver Metastasis AxisTetiana Y Bowley, Mireya C Ortiz, Irina V Lagutina, et al.Journal of Translational Medicine|November 5, 2023
Deep neural network based tissue deconvolution of circulating tumor cell RNAFengyao Yan, Limin Jiang, Fei Ye, et al.Cancer Research Communications|November 21, 2022
The RPL/RPS gene signature of melanoma CTCs associates with brain metastasisTetiana Y Bowley, Irina V Lagutina, Carol Francis, et al.Cancer Research|July 21, 2018
Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow-Resident Melanoma CTCsMonika Vishnoi, Debasish Boral, Haowen Liu, et al.Pageof 5